About this trial
The REgistry Study on multimodality trEAtment foR Cerebral Hemorrhage (RESEARCH) aims to address these challenges by establishing a comprehensive national registry. This initiative will collect detailed, longitudinal data on the clinical characteristics, treatment modalities, and outcomes of patients with ICH across various regions. By leveraging a wide array of treatment data - including medical management, surgical interventions, and rehabilitative strategies - the RESEARCH registry intends to provide a granular view of current treatment landscapes and their direct impact on patient recovery and quality of life.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Cerebral hemorrhage
Disqualifiers
None
Trial population
Cerebral hemorrhage from various causes
Trial design
Cohort
Prospective
Treatments tested in this trial
medical management, surgical interventions, and rehabilitative strategies
Other interventionBy leveraging a wide array of treatment data - including medical management, surgical interventions, and rehabilitative strategies - the RESEARCH registry intends to provide a granular view of current treatment landscapes and their direct impact on patient recovery and quality of life.
Treatment groups
Trial outcomes
Primary outcomes
modified Rankin Score (mRS)
0=no symptoms, 1=no significant disability, 2=slight disability, 3= moderate disability, 4=moderate severe disability, 5=severe disability, 6=death
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Tao Liu
Lead sponsor
The George Institute
Sponsor institution
Tianjin Medical University General Hospital
Collaborator
Xuanwu Hospital, Beijing
Collaborator
This trial is not recruiting at the moment. You can still explore other options: